Symbols / MDT Stock $83.32 -0.56% Medtronic plc

Healthcare • Medical Devices • Ireland • NYQ
MDT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Geoffrey Straub Martha
Exch · Country NYQ · Ireland
Market Cap 106.97B
Enterprise Value 126.87B
Income 4.61B
Sales 35.48B
FCF (ttm) 4.07B
Book/sh 38.17
Cash/sh 6.53
Employees 95,000
Insider 10d —
IPO May 02, 1973
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 79.05%
P/E 23.27
Forward P/E 13.75
PEG 1.45
P/S 3.01
P/B 2.18
P/C —
EV/EBITDA 13.44
EV/Sales 3.58
Quick Ratio 1.55
Current Ratio 2.54
Debt/Eq 57.06
LT Debt/Eq —
EPS (ttm) 3.58
EPS next Y 6.06
EPS Growth -11.80%
Revenue Growth 8.70%
EPS Gr Q/Q -11.70%
Rev Gr Q/Q —
Earnings (next) 2026-06-03
Earnings (prior) 2026-02-17
ROA 4.57%
ROE 9.39%
ROIC —
Gross Margin 65.16%
Oper. Margin 20.01%
Profit Margin 13.00%
Shs Outstand 1.28B
Shs Float 1.28B
Insider Own 0.32%
Instit Own 88.09%
Short Float 1.21%
Short Ratio 1.96
Short Interest 15.46M
52W High 106.33
vs 52W High -21.64%
52W Low 79.93
vs 52W Low 4.24%
Beta 0.76
Impl. Vol. 27.10%
Rel Volume 0.62
Avg Volume 8.59M
Volume 5.34M
Target (mean) $108.00
Tgt Median $110.00
Tgt Low $90.00
Tgt High $121.00
# Analysts 25
Recom Buy
Prev Close $83.79
Price $83.32
Change -0.56%
About

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$108.00
Mean price target
2. Current target
$83.32
Latest analyst target
3. DCF / Fair value
$57.11
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$83.32
Low
$90.00
High
$121.00
Mean
$108.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-22 main UBS Neutral → Neutral $90
2026-04-15 main Truist Securities Hold → Hold $95
2026-04-13 main Mizuho Outperform → Outperform $120
2026-04-09 main Evercore ISI Group Outperform → Outperform $106
2026-04-07 main Citigroup Buy → Buy $110
2026-04-06 main Evercore ISI Group Outperform → Outperform $108
2026-04-06 main Argus Research Buy → Buy $115
2026-04-01 main Barclays Overweight → Overweight $120
2026-04-01 main Piper Sandler Neutral → Neutral $91
2026-03-26 reit Needham Buy → Buy $120
2026-03-10 reit Needham Buy → Buy $120
2026-02-18 main JP Morgan Neutral → Neutral $100
2026-02-18 main Barclays Overweight → Overweight $118
2026-02-18 main Baird Neutral → Neutral $100
2026-02-17 main Needham Buy → Buy $120
2026-02-09 up Needham Hold → Buy $121
2026-01-09 main Bernstein Outperform → Outperform $112
2026-01-08 main Barclays Overweight → Overweight $116
2026-01-06 up William Blair Market Perform → Outperform —
2025-12-18 main Truist Securities Hold → Hold $107
News
RSS: Latest MDT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-20 BLOMQUIST DENISE L Officer — 340 $0.00 $0
2026-02-19 KIIL HARRY SKIP Officer — 52,524 $97.66 $5,132,217
2026-02-19 KIIL HARRY SKIP Officer — 50,876 $80.00 $4,624,512
2025-11-20 BLOMQUIST DENISE L Officer — 170 $0.00 $0
2025-11-19 SMITH GREGORY L Officer — 30,000 $101.93 $3,058,451
2025-09-03 KIIL HARRY SKIP Officer — 8,605 $91.58 $788,048
2025-08-25 JELLISON WILLIAM R Director — 5,000 $92.37 $462,750
2025-08-01 BLOMQUIST DENISE L Officer — 518 $78.00 $16,692
2025-08-01 SMITH GREGORY L Officer — 11,328 — —
2025-08-01 MARTHA GEOFFREY S Chief Executive Officer — 98,324 $78.00 $3,166,800
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-04-30 2024-04-30 2023-04-30 2022-04-30
Total Revenue
33,537.00
+3.62%
32,364.00
+3.64%
31,227.00
-1.45%
31,686.00
Operating Revenue
33,537.00
+3.62%
32,364.00
+3.64%
31,227.00
-1.45%
31,686.00
Cost Of Revenue
11,632.00
+3.71%
11,216.00
+4.64%
10,719.00
+5.66%
10,145.00
Reconciled Cost Of Revenue
10,578.00
+3.08%
10,262.00
+5.58%
9,720.00
+5.99%
9,171.00
Gross Profit
21,905.00
+3.58%
21,148.00
+3.12%
20,508.00
-4.80%
21,541.00
Operating Expense
15,365.00
-1.68%
15,628.00
+6.47%
14,678.00
-6.11%
15,633.00
Research And Development
2,732.00
-0.11%
2,735.00
+1.45%
2,696.00
-1.82%
2,746.00
Selling General And Administration
10,849.00
+1.05%
10,736.00
+3.08%
10,415.00
+1.20%
10,292.00
Other Operating Expenses
-23.00
-104.96%
464.00
+454.20%
-131.00
-115.20%
862.00
Total Expenses
26,997.00
+0.57%
26,844.00
+5.70%
25,397.00
-1.48%
25,778.00
Operating Income
6,540.00
+18.48%
5,520.00
-5.32%
5,830.00
-1.32%
5,908.00
Total Operating Income As Reported
5,955.00
+15.77%
5,144.00
-6.22%
5,485.00
-4.64%
5,752.00
EBITDA
9,218.00
+12.37%
8,203.00
-5.68%
8,697.00
-0.91%
8,777.00
Normalized EBITDA
9,802.00
+14.27%
8,578.00
-5.13%
9,042.00
+1.23%
8,932.00
Reconciled Depreciation
2,861.00
+8.08%
2,647.00
-1.85%
2,697.00
-0.37%
2,707.00
EBIT
6,357.00
+14.42%
5,556.00
-7.40%
6,000.00
-1.15%
6,070.00
Total Unusual Items
-584.00
-55.73%
-375.00
-8.70%
-345.00
-122.58%
-155.00
Total Unusual Items Excluding Goodwill
-584.00
-55.73%
-375.00
-8.70%
-345.00
-122.58%
-155.00
Special Income Charges
-584.00
-55.73%
-375.00
-8.70%
-345.00
-122.58%
-155.00
Other Special Charges
317.00
+112.75%
149.00
+596.67%
-30.00
-131.58%
95.00
Restructuring And Mergern Acquisition
267.00
+18.14%
226.00
-39.73%
375.00
+525.00%
60.00
Net Income
4,662.00
+26.82%
3,676.00
-2.18%
3,758.00
-25.42%
5,039.00
Pretax Income
5,628.00
+16.35%
4,837.00
-9.82%
5,364.00
-2.77%
5,517.00
Net Non Operating Interest Income Expense
-729.00
-1.39%
-719.00
-13.05%
-636.00
-15.01%
-553.00
Interest Expense Non Operating
729.00
+1.39%
719.00
+13.05%
636.00
+15.01%
553.00
Net Interest Income
-729.00
-1.39%
-719.00
-13.05%
-636.00
-15.01%
-553.00
Interest Expense
729.00
+1.39%
719.00
+13.05%
636.00
+15.01%
553.00
Other Income Expense
-182.00
-591.89%
37.00
-78.24%
170.00
+4.29%
163.00
Other Non Operating Income Expenses
402.00
-2.43%
412.00
-20.00%
515.00
+61.95%
318.00
Tax Provision
936.00
-17.39%
1,133.00
-28.29%
1,580.00
+246.49%
456.00
Tax Rate For Calcs
0.00
-29.06%
0.00
-20.68%
0.00
+255.42%
0.00
Tax Effect Of Unusual Items
-96.94
-10.48%
-87.75
+13.78%
-101.78
-691.10%
-12.87
Net Income Including Noncontrolling Interests
4,691.00
+26.61%
3,705.00
-2.09%
3,784.00
-25.25%
5,062.00
Net Income From Continuing Operation Net Minority Interest
4,662.00
+26.82%
3,676.00
-2.18%
3,758.00
-25.42%
5,039.00
Net Income From Continuing And Discontinued Operation
4,662.00
+26.82%
3,676.00
-2.18%
3,758.00
-25.42%
5,039.00
Net Income Continuous Operations
4,691.00
+26.61%
3,705.00
-2.09%
3,784.00
-25.25%
5,062.00
Minority Interests
-29.00
-3.57%
-28.00
-7.69%
-26.00
-18.18%
-22.00
Normalized Income
5,149.06
+29.92%
3,963.25
-0.95%
4,001.22
-22.77%
5,181.14
Net Income Common Stockholders
4,662.00
+26.82%
3,676.00
-2.18%
3,758.00
-25.42%
5,039.00
Diluted EPS
3.61
+30.80%
2.76
-2.13%
2.82
-24.40%
3.73
Basic EPS
3.63
+31.05%
2.77
-2.12%
2.83
-24.53%
3.75
Basic Average Shares
1,285.60
-3.17%
1,327.70
-0.16%
1,329.80
-0.94%
1,342.40
Diluted Average Shares
1,289.90
-3.03%
1,330.20
-0.20%
1,332.80
-1.38%
1,351.40
Diluted NI Availto Com Stockholders
4,662.00
+26.82%
3,676.00
-2.18%
3,758.00
-25.42%
5,039.00
Amortization
1,807.00
+6.73%
1,693.00
-0.29%
1,698.00
-2.02%
1,733.00
Amortization Of Intangibles Income Statement
1,807.00
+6.73%
1,693.00
-0.29%
1,698.00
-2.02%
1,733.00
Depreciation Amortization Depletion Income Statement
1,807.00
+6.73%
1,693.00
-0.29%
1,698.00
-2.02%
1,733.00
Depreciation And Amortization In Income Statement
1,807.00
+6.73%
1,693.00
-0.29%
1,698.00
-2.02%
1,733.00
Line Item Trend 2025-04-30 2024-04-30 2023-04-30 2022-04-30
Total Assets
91,680.00
+1.89%
89,981.00
-1.06%
90,948.00
-0.04%
90,981.00
Current Assets
23,814.00
+8.57%
21,935.00
+1.20%
21,675.00
-6.00%
23,059.00
Cash Cash Equivalents And Short Term Investments
8,965.00
+11.99%
8,005.00
+0.58%
7,959.00
-24.72%
10,573.00
Cash And Cash Equivalents
2,218.00
+72.74%
1,284.00
-16.79%
1,543.00
-58.45%
3,714.00
Other Short Term Investments
6,747.00
+0.39%
6,721.00
+4.75%
6,416.00
-6.46%
6,859.00
Receivables
6,515.00
+6.32%
6,128.00
+2.17%
5,998.00
+8.05%
5,551.00
Accounts Receivable
6,515.00
+6.32%
6,128.00
+2.17%
5,998.00
+8.05%
5,551.00
Gross Accounts Receivable
6,714.00
+6.55%
6,301.00
+2.06%
6,174.00
+6.80%
5,781.00
Allowance For Doubtful Accounts Receivable
-199.00
-15.03%
-173.00
+1.70%
-176.00
+23.48%
-230.00
Inventory
5,476.00
+4.96%
5,217.00
-1.44%
5,293.00
+14.67%
4,616.00
Raw Materials
953.00
+5.07%
907.00
-14.68%
1,063.00
+23.03%
864.00
Work In Process
744.00
+15.89%
642.00
-18.63%
789.00
+15.69%
682.00
Finished Goods
3,779.00
+3.03%
3,668.00
+6.63%
3,440.00
+12.05%
3,070.00
Other Current Assets
2,858.00
+10.56%
2,585.00
+6.60%
2,425.00
+4.57%
2,319.00
Total Non Current Assets
67,865.00
-0.27%
68,046.00
-1.77%
69,274.00
+1.99%
67,920.00
Net PPE
6,837.00
+11.52%
6,131.00
+10.09%
5,569.00
+2.88%
5,413.00
Gross PPE
15,636.00
+11.26%
14,053.00
-0.06%
14,062.00
+5.22%
13,365.00
Accumulated Depreciation
-8,799.00
-11.07%
-7,922.00
+6.72%
-8,493.00
-6.80%
-7,952.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
160.00
+0.63%
159.00
-1.85%
162.00
-4.71%
170.00
Buildings And Improvements
2,685.00
+7.14%
2,506.00
+0.76%
2,487.00
+5.78%
2,351.00
Machinery Furniture Equipment
3,295.00
+14.73%
2,872.00
-2.71%
2,952.00
+12.80%
2,617.00
Construction In Progress
2,340.00
+10.43%
2,119.00
+20.81%
1,754.00
+0.98%
1,737.00
Other Properties
7,156.00
+11.88%
6,396.00
-4.64%
6,707.00
+3.34%
6,490.00
Goodwill And Other Intangible Assets
53,404.00
-1.49%
54,211.00
-3.66%
56,269.00
+0.31%
56,096.00
Goodwill
41,737.00
+1.83%
40,986.00
-1.06%
41,425.00
+2.28%
40,502.00
Other Intangible Assets
11,667.00
-11.78%
13,225.00
-10.91%
14,844.00
-4.81%
15,594.00
Non Current Accounts Receivable
4,040.00
+10.47%
3,657.00
+5.18%
3,477.00
+2.17%
3,403.00
Other Non Current Assets
3,584.00
-11.44%
4,047.00
+2.22%
3,959.00
+31.62%
3,008.00
Total Liabilities Net Minority Interest
43,424.00
+9.76%
39,561.00
+0.71%
39,283.00
+2.68%
38,259.00
Current Liabilities
12,879.00
+19.37%
10,789.00
+19.20%
9,051.00
-26.97%
12,394.00
Payables And Accrued Expenses
7,490.00
+2.29%
7,322.00
+3.37%
7,083.00
+8.45%
6,531.00
Payables
3,807.00
+1.79%
3,740.00
+6.80%
3,502.00
+17.52%
2,980.00
Accounts Payable
2,449.00
+1.62%
2,410.00
-9.47%
2,662.00
+16.96%
2,276.00
Current Accrued Expenses
3,683.00
+2.82%
3,582.00
+0.03%
3,581.00
+0.84%
3,551.00
Employee Benefits
1,158.00
+5.18%
1,101.00
+0.73%
1,093.00
-1.80%
1,113.00
Pensionand Other Post Retirement Benefit Plans Current
2,514.00
+5.85%
2,375.00
+21.86%
1,949.00
-8.11%
2,121.00
Total Tax Payable
1,358.00
+2.11%
1,330.00
+58.33%
840.00
+19.32%
704.00
Income Tax Payable
1,358.00
+2.11%
1,330.00
+58.33%
840.00
+19.32%
704.00
Current Debt And Capital Lease Obligation
2,874.00
+163.19%
1,092.00
+5360.00%
20.00
-99.47%
3,742.00
Current Debt
2,868.00
+164.09%
1,086.00
+8253.85%
13.00
-99.65%
3,736.00
Other Current Borrowings
2,855.00
—
13.00
-99.65%
3,724.00
Current Capital Lease Obligation
6.00
+0.00%
6.00
-14.29%
7.00
+16.67%
6.00
Other Current Liabilities
1.00
—
-1.00
—
Total Non Current Liabilities Net Minority Interest
30,545.00
+6.16%
28,772.00
-4.83%
30,232.00
+16.88%
25,865.00
Long Term Debt And Capital Lease Obligation
25,642.00
+7.15%
23,932.00
-1.69%
24,344.00
+19.50%
20,372.00
Long Term Debt
25,590.00
+7.17%
23,877.00
-1.69%
24,287.00
+19.55%
20,316.00
Long Term Capital Lease Obligation
52.00
-5.45%
55.00
-3.51%
57.00
+1.79%
56.00
Tradeand Other Payables Non Current
1,574.00
-15.33%
1,859.00
-21.23%
2,360.00
+13.08%
2,087.00
Non Current Deferred Liabilities
403.00
-21.75%
515.00
-27.26%
708.00
-19.91%
884.00
Non Current Deferred Taxes Liabilities
403.00
-21.75%
515.00
-27.26%
708.00
-19.91%
884.00
Other Non Current Liabilities
1,768.00
+29.52%
1,365.00
-20.96%
1,727.00
+22.57%
1,409.00
Stockholders Equity
48,024.00
-4.36%
50,214.00
-2.46%
51,483.00
-2.03%
52,551.00
Common Stock Equity
48,024.00
-4.36%
50,214.00
-2.46%
51,483.00
-2.03%
52,551.00
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Share Issued
1,281.93
-2.24%
1,311.34
-1.46%
1,330.81
+0.00%
1,330.74
Ordinary Shares Number
1,281.93
-2.24%
1,311.34
-1.46%
1,330.81
+0.00%
1,330.74
Additional Paid In Capital
20,833.00
-9.93%
23,129.00
-5.94%
24,590.00
+0.10%
24,566.00
Retained Earnings
31,476.00
+3.53%
30,403.00
+0.04%
30,392.00
+0.47%
30,250.00
Gains Losses Not Affecting Retained Earnings
-4,284.00
-29.11%
-3,318.00
+5.17%
-3,499.00
-54.48%
-2,265.00
Minority Interest
232.00
+12.62%
206.00
+13.19%
182.00
+6.43%
171.00
Other Equity Adjustments
-4,284.00
-29.11%
-3,318.00
+5.17%
-3,499.00
-54.48%
-2,265.00
Total Equity Gross Minority Interest
48,256.00
-4.29%
50,420.00
-2.41%
51,665.00
-2.00%
52,722.00
Total Capitalization
73,614.00
-0.64%
74,091.00
-2.22%
75,770.00
+3.98%
72,867.00
Working Capital
10,935.00
-1.89%
11,146.00
-11.71%
12,624.00
+18.37%
10,665.00
Invested Capital
76,482.00
+1.74%
75,177.00
-0.80%
75,783.00
-1.07%
76,603.00
Total Debt
28,516.00
+13.95%
25,024.00
+2.71%
24,364.00
+1.04%
24,114.00
Net Debt
26,240.00
+10.82%
23,679.00
+4.05%
22,757.00
+11.89%
20,338.00
Capital Lease Obligations
58.00
-4.92%
61.00
-4.69%
64.00
+3.23%
62.00
Net Tangible Assets
-5,380.00
-34.60%
-3,997.00
+16.49%
-4,786.00
-35.01%
-3,545.00
Tangible Book Value
-5,380.00
-34.60%
-3,997.00
+16.49%
-4,786.00
-35.01%
-3,545.00
Commercial Paper
0.00
-100.00%
1,073.00
0.00
—
Line Of Credit
13.00
+0.00%
13.00
+0.00%
13.00
+8.33%
12.00
Other Equity Interest
-1.00
—
—
—
Other Inventories
—
—
1.00
—
Line Item Trend 2025-04-30 2024-04-30 2023-04-30 2022-04-30
Operating Cash Flow
7,044.00
+3.79%
6,787.00
+12.39%
6,039.00
-17.79%
7,346.00
Cash Flow From Continuing Operating Activities
7,044.00
+3.79%
6,787.00
+12.39%
6,039.00
-17.79%
7,346.00
Net Income From Continuing Operations
4,691.00
+26.61%
3,705.00
-2.09%
3,784.00
-25.25%
5,062.00
Depreciation Amortization Depletion
2,861.00
+8.08%
2,647.00
-1.85%
2,697.00
-0.37%
2,707.00
Depreciation
1,054.00
+10.48%
954.00
-4.50%
999.00
+2.57%
974.00
Amortization Cash Flow
1,807.00
+6.73%
1,693.00
-0.29%
1,698.00
-2.02%
1,733.00
Depreciation And Amortization
2,861.00
+8.08%
2,647.00
-1.85%
2,697.00
-0.37%
2,707.00
Amortization Of Intangibles
1,807.00
+6.73%
1,693.00
-0.29%
1,698.00
-2.02%
1,733.00
Other Non Cash Items
310.00
-45.90%
573.00
+112.22%
270.00
+95.65%
138.00
Stock Based Compensation
429.00
+9.16%
393.00
+10.70%
355.00
-1.11%
359.00
Provisionand Write Offof Assets
123.00
+36.67%
90.00
+23.29%
73.00
+25.86%
58.00
Asset Impairment Charge
0.00
-100.00%
371.00
0.00
-100.00%
515.00
Deferred Tax
-316.00
+37.80%
-508.00
-124.78%
-226.00
+62.58%
-604.00
Deferred Income Tax
-316.00
+37.80%
-508.00
-124.78%
-226.00
+62.58%
-604.00
Operating Gains Losses
—
—
53.00
—
Change In Working Capital
-1,054.00
-117.77%
-484.00
+49.95%
-967.00
-8.77%
-889.00
Change In Receivables
-433.00
-10.74%
-391.00
+32.12%
-576.00
-20.75%
-477.00
Changes In Account Receivables
-433.00
-10.74%
-391.00
+32.12%
-576.00
-20.75%
-477.00
Change In Inventory
-292.00
-110.07%
-139.00
+85.20%
-939.00
-67.68%
-560.00
Change In Payables And Accrued Expense
209.00
-46.55%
391.00
-43.82%
696.00
+226.76%
213.00
Change In Other Working Capital
-538.00
-55.94%
-345.00
-133.11%
-148.00
-127.69%
-65.00
Investing Cash Flow
-1,937.00
+18.13%
-2,366.00
+32.26%
-3,493.00
-110.55%
-1,659.00
Cash Flow From Continuing Investing Activities
-1,937.00
+18.13%
-2,366.00
+32.26%
-3,493.00
-110.55%
-1,659.00
Net PPE Purchase And Sale
-1,859.00
-17.14%
-1,587.00
-8.77%
-1,459.00
-6.65%
-1,368.00
Purchase Of PPE
-1,859.00
-17.14%
-1,587.00
-8.77%
-1,459.00
-6.65%
-1,368.00
Capital Expenditure
-1,859.00
-17.14%
-1,587.00
-8.77%
-1,459.00
-6.65%
-1,368.00
Net Investment Purchase And Sale
269.00
+187.62%
-307.00
-79.53%
-171.00
+10.00%
-190.00
Purchase Of Investment
-8,226.00
-6.17%
-7,748.00
-3.11%
-7,514.00
+23.96%
-9,882.00
Sale Of Investment
8,495.00
+14.16%
7,441.00
+1.33%
7,343.00
-24.24%
9,692.00
Net Business Purchase And Sale
-98.00
+53.55%
-211.00
+88.70%
-1,867.00
-1951.65%
-91.00
Purchase Of Business
-98.00
+53.55%
-211.00
+88.70%
-1,867.00
-1951.65%
-91.00
Net Other Investing Changes
-249.00
+4.60%
-261.00
-6625.00%
4.00
+140.00%
-10.00
Financing Cash Flow
-4,361.00
+2.00%
-4,450.00
+10.28%
-4,960.00
+7.05%
-5,336.00
Cash Flow From Continuing Financing Activities
-4,361.00
+2.00%
-4,450.00
+10.28%
-4,960.00
+7.05%
-5,336.00
Net Issuance Payments Of Debt
2,139.00
+99.35%
1,073.00
+279.43%
-598.00
-59700.00%
-1.00
Issuance Of Debt
3,209.00
+199.07%
1,073.00
-86.05%
7,693.00
0.00
Repayment Of Debt
-1,070.00
0.00
+100.00%
-8,291.00
-829000.00%
-1.00
Long Term Debt Issuance
3,209.00
0.00
-100.00%
5,409.00
0.00
Long Term Debt Payments
0.00
0.00
+100.00%
-6,012.00
-601100.00%
-1.00
Net Long Term Debt Issuance
3,209.00
0.00
+100.00%
-603.00
-60200.00%
-1.00
Short Term Debt Issuance
0.00
-100.00%
1,073.00
-53.02%
2,284.00
0.00
Short Term Debt Payments
-1,070.00
0.00
+100.00%
-2,279.00
0.00
Net Short Term Debt Issuance
-1,070.00
-199.72%
1,073.00
+21360.00%
5.00
0.00
Net Common Stock Issuance
-2,727.00
-47.09%
-1,854.00
-450.15%
-337.00
+84.07%
-2,115.00
Common Stock Payments
-3,235.00
-51.31%
-2,138.00
-231.47%
-645.00
+74.65%
-2,544.00
Common Stock Dividend Paid
-3,589.00
+2.10%
-3,666.00
-1.38%
-3,616.00
-6.89%
-3,383.00
Cash Dividends Paid
-3,589.00
+2.10%
-3,666.00
-1.38%
-3,616.00
-6.89%
-3,383.00
Repurchase Of Capital Stock
-3,235.00
-51.31%
-2,138.00
-231.47%
-645.00
+74.65%
-2,544.00
Net Other Financing Charges
-184.00
-6033.33%
-3.00
+99.27%
-409.00
-350.92%
163.00
Changes In Cash
746.00
+2672.41%
-29.00
+98.80%
-2,414.00
-785.80%
352.00
Effect Of Exchange Rate Changes
188.00
+181.74%
-230.00
-194.65%
243.00
+205.19%
-231.00
Beginning Cash Position
1,284.00
-16.79%
1,543.00
-58.45%
3,714.00
+3.37%
3,593.00
End Cash Position
2,218.00
+72.74%
1,284.00
-16.79%
1,543.00
-58.45%
3,714.00
Free Cash Flow
5,185.00
-0.29%
5,200.00
+13.54%
4,580.00
-23.39%
5,978.00
Interest Paid Supplemental Data
762.00
-7.75%
826.00
+36.30%
606.00
+12.22%
540.00
Income Tax Paid Supplemental Data
1,819.00
+12.15%
1,622.00
+4.78%
1,548.00
+55.42%
996.00
Common Stock Issuance
508.00
+78.87%
284.00
-7.79%
308.00
-28.21%
429.00
Issuance Of Capital Stock
508.00
+78.87%
284.00
-7.79%
308.00
-28.21%
429.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category